CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME

PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peak...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IUSTAIN CARMEN, ADIN ITAI, FUTERMAN YURI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator IUSTAIN CARMEN
ADIN ITAI
FUTERMAN YURI
description PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&INPIT
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2007308494A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2007308494A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2007308494A3</originalsourceid><addsrcrecordid>eNrjZLBxDooMDnH08fH0c1Xw9HUM8fTzdFJwcgx2VXD0c1EICPJ3dg0OVnDzDwKxXUKdPf3cFUI8XBWCHX1deRhY0xJzilN5oTQ3g5Kba4izh25qQX58anFBYnJqXmpJvFeAkYGBubGBhYmliaMxUYoASb8p3g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><source>esp@cenet</source><creator>IUSTAIN CARMEN ; ADIN ITAI ; FUTERMAN YURI</creator><creatorcontrib>IUSTAIN CARMEN ; ADIN ITAI ; FUTERMAN YURI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&amp;INPIT</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071129&amp;DB=EPODOC&amp;CC=JP&amp;NR=2007308494A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071129&amp;DB=EPODOC&amp;CC=JP&amp;NR=2007308494A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IUSTAIN CARMEN</creatorcontrib><creatorcontrib>ADIN ITAI</creatorcontrib><creatorcontrib>FUTERMAN YURI</creatorcontrib><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><description>PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&amp;INPIT</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBxDooMDnH08fH0c1Xw9HUM8fTzdFJwcgx2VXD0c1EICPJ3dg0OVnDzDwKxXUKdPf3cFUI8XBWCHX1deRhY0xJzilN5oTQ3g5Kba4izh25qQX58anFBYnJqXmpJvFeAkYGBubGBhYmliaMxUYoASb8p3g</recordid><startdate>20071129</startdate><enddate>20071129</enddate><creator>IUSTAIN CARMEN</creator><creator>ADIN ITAI</creator><creator>FUTERMAN YURI</creator><scope>EVB</scope></search><sort><creationdate>20071129</creationdate><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><author>IUSTAIN CARMEN ; ADIN ITAI ; FUTERMAN YURI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2007308494A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IUSTAIN CARMEN</creatorcontrib><creatorcontrib>ADIN ITAI</creatorcontrib><creatorcontrib>FUTERMAN YURI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IUSTAIN CARMEN</au><au>ADIN ITAI</au><au>FUTERMAN YURI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME</title><date>2007-11-29</date><risdate>2007</risdate><abstract>PROBLEM TO BE SOLVED: To provide a crystalline imatinib base form I suitable for preparing an imatinib salt such as a mesylate salt, and a process for producing it. SOLUTION: The crystalline imatinib base form I characterized by the X-ray powder diffraction pattern that shows strong diffraction peaks at 2θ of 6.0, 17.2, 18.1, 18.7, 19.8, 20.9, 23.8, 24.3 and 25.2±0.2 degrees is provided. A process for preparing the imatinib salts from the crystalline imatinib base form I is also provided. COPYRIGHT: (C)2008,JPO&amp;INPIT</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2007308494A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title CRYSTALLINE IMATINIB BASE AND PROCESS FOR PRODUCING THE SAME
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A59%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IUSTAIN%20CARMEN&rft.date=2007-11-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2007308494A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true